跳至主要内容
临床试验/NCT05696886
NCT05696886已完成不适用

The Effect of Intraoperative Tramadol on Postoperative Opioid Requirements After Laparoscopic Sleeve Gastrectomy for Morbid Obese Patients (A Retrospective Multicentric Cohort Study)

Mansoura University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2021年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
1
主要终点
VAS of pain

研究概览

简要总结

Postoperative pain remains a very UNPLEASENTevent, particularly in morbidly obese patients that may be associated with obstructive sleep apnea. Bariatric surgery patients must get safe and efficient analgesia, which is essential given that up to 45 % of patients report substantial pain in the first two days following surgery. The study's purpose was to compare the efficacy and safety of combined tramadol with pethidine versus pethidine alone and to assess their impact on postoperative pethidine requirements after LSG for morbidly obese patients

详细描述

This multicenter cohort research included patients with morbid obesity who had LSG between January 2021 and December 2022. The patients included in the study were allocated to one of two treatment groups that were not randomized but the patients were categorized according to the time of surgery: Group A received Pethidine alone in the period between January 2021 and December 2021, while Group B got Tramadol with pethidine in the period between January 2022 and December 2022. Doses were based on the patient's actual body weight.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Group A received Pethidine alone in the period between January 2021 and December 2021, while Group B got Tramadol with pethidine in the period between January 2022 and December 2022. Doses were based on the patient's actual body weight.

入排标准

年龄范围
16 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with morbid obesity defined as a BMI of more than 40 or
  • BMI less than 35 with at least one comorbidity and
  • ages ranging from 16 to 65, were patients

排除标准

  • Patients under the age of 16 or over 65,
  • Those with severe GERD, leakage
  • pregnancy, or
  • inflammatory bowel disease,

研究组 & 干预措施

Group A received Pethidine alone in the period between January 2021 and December 2021,

Active Comparator

received Pethidine alone in the period between January 2021 and December 2021, while

干预措施: Pethidine (Drug)

Group B got Tramadol with pethidine in the period between January 2022 and December 2022.

Active Comparator

Group B got Tramadol with pethidine in the period between January 2022 and December 2022.

干预措施: Tramadol with pethidine (Drug)

结局指标

主要结局

VAS of pain

时间窗: 48 hours postoperative

the severity of pain

opioid requirement

时间窗: one month

the need of pethidine

次要结局

  • hospital stay(one month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ayman El Nakeeb

Clinical Professor, Gastroenterology surgical center, mansoura university

Mansoura University

研究点 (1)

Loading locations...

相似试验